Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiology of thin endometrial lining and euploid single embryo transfer outcomes.

Reproductive biomedicine online·2026
Same author

Preimplantation genetic testing for aneuploidy in donor egg recipients does not decrease number of embryo transfers needed to achieve live birth.

Fertility and sterility·2026
Same author

Prognostic utility of serum beta human chorionic gonadotropin level following single euploid embryo transfer for live birth.

Fertility and sterility·2026
Same author

Mature oocyte yield in patients with diminished ovarian reserve treated with luteal estradiol priming with or without GnRH antagonist.

Minerva obstetrics and gynecology·2026
Same author

Pearling drives mitochondrial DNA nucleoid distribution.

Science (New York, N.Y.)·2026
Same author

Survey of work-from-home experiences among medical physicists in Southern California during and after the COVID-19 pandemic.

Journal of applied clinical medical physics·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment
07:03

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment

Published on: July 23, 2011

29.9K

Optimizing oocyte yield utilizing a machine learning model for dose and trigger decisions, a multi-center,

Chelsea Canon1, Lily Leibner1, Michael Fanton2

  • 1RMA of New York, 635 Madison Avenue, 10th Floor, New York, NY, 10022, USA.

Scientific Reports
|August 20, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) assisted clinicians in optimizing follicle stimulating hormone (FSH) dosage and trigger timing for in vitro fertilization (IVF). While not statistically significant, AI use showed trends toward improved outcomes and reduced FSH consumption in IVF cycles.

Keywords:
Artificial intelligenceClinical studyEmbryo selectionMachine learning

More Related Videos

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
10:04

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes

Published on: March 3, 2018

6.6K
Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
12:36

Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse

Published on: September 3, 2021

4.6K

Related Experiment Videos

Last Updated: May 9, 2026

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment
07:03

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment

Published on: July 23, 2011

29.9K
A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
10:04

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes

Published on: March 3, 2018

6.6K
Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse
12:36

Whole Ovary Immunofluorescence, Clearing, and Multiphoton Microscopy for Quantitative 3D Analysis of the Developing Ovarian Reserve in Mouse

Published on: September 3, 2021

4.6K

Area of Science:

  • Reproductive Medicine
  • Clinical Trials
  • Artificial Intelligence in Healthcare

Background:

  • In vitro fertilization (IVF) treatment relies on precise hormonal stimulation and timing for optimal outcomes.
  • Determining the ideal starting dose of follicle stimulating hormone (FSH) and trigger injection timing can be complex.
  • Artificial intelligence (AI) offers potential for data-driven decision support in clinical workflows.

Purpose of the Study:

  • To evaluate the clinical outcomes of IVF patients when clinicians utilized an AI platform.
  • To assess AI's impact on determining the optimal starting dose of FSH and trigger injection timing.
  • To compare patient outcomes between AI-assisted and conventional IVF treatment protocols.

Main Methods:

  • A prospective clinical trial with a historical control arm was conducted.
  • Four physicians across two US fertility centers participated.
  • The treatment group (N=291) used AI for FSH dose and trigger timing; the control group received standard care.
  • Key outcome measures included total FSH used and the average number of mature metaphase II (MII) oocytes retrieved.

Main Results:

  • The AI-assisted group showed a trend towards improved outcomes, with an average of 12.20 MII oocytes versus 11.24 in the control group (p=0.16).
  • Average oocytes retrieved were 16.01 (AI group) vs. 14.54 (control group), indicating a potential benefit (p=0.08).
  • The AI group used less total FSH (3671.95 IUs) compared to the control group (3846.29 IUs), a difference of -174.35 IUs (p=0.13).

Conclusions:

  • AI can safely assist clinicians in refining FSH starting doses and trigger injection timing during ovarian stimulation.
  • Physician use of AI in IVF demonstrates a potential to optimize the number of MII oocytes retrieved.
  • Further research may confirm AI's role in enhancing IVF treatment efficiency and patient outcomes.